A University of Otago-led study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a new way to kill them.
Viatris downsizes; Biovectra partners with Acuitas; Pfizer’s Hospira recalls injections; WuXi secures two new deals
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls, and more. This week we saw multiple CDMO